drugset / Trial / NCT01403259
SOX as Salvage Treatment in Nasopharyngeal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The aim of the study is to evaluate the efficacy and safety of SOX regimen (S-1 plus oxaliplatin) as salvage treatment in patients with relapsed or metastatic nasopharyngeal carcinoma.
Timeline
- Start
- 2011-07
- Primary completion
- 2014-12
- Completion
- 2015-12
Outcome
Outcome not reported
Stopped (Enrollment): “poor accrual of eligible patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | 100 mg/m2 | — |
| Subject | S-1 | Small molecule | 60 mg | — |